JNBA Financial Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.7K | Hold |
140
| – | – | ﹤0.01% | 490 |
|
|
2025
Q1 | $9.9K | Hold |
140
| – | – | ﹤0.01% | 460 |
|
|
2024
Q4 | $9.2K | Hold |
140
| – | – | ﹤0.01% | 469 |
|
|
2024
Q3 | $9.84K | Hold |
140
| – | – | ﹤0.01% | 460 |
|
|
2024
Q2 | $11.5K | Hold |
140
| – | – | ﹤0.01% | 440 |
|
|
2024
Q1 | $12.2K | Sell |
140
-3
| -2% | -$262 | ﹤0.01% | 447 |
|
|
2023
Q4 | $13.8K | Hold |
143
| – | – | ﹤0.01% | 432 |
|
|
2023
Q3 | $12.7K | Buy |
143
+3
| +2% | +$265 | ﹤0.01% | 440 |
|
|
2023
Q2 | $12.1K | Hold |
140
| – | – | ﹤0.01% | 443 |
|
|
2023
Q1 | $13.6K | Hold |
140
| – | – | ﹤0.01% | 439 |
|
|
2022
Q4 | $14.5K | Sell |
140
-22
| -14% | -$2.28K | ﹤0.01% | 410 |
|
|
2022
Q3 | $14K | Buy |
162
+22
| +16% | +$1.9K | ﹤0.01% | 417 |
|
|
2022
Q2 | $12K | Hold |
140
| – | – | ﹤0.01% | 465 |
|
|
2022
Q1 | $11K | Sell |
140
-10
| -7% | -$786 | ﹤0.01% | 487 |
|
|
2021
Q4 | $13K | Buy |
150
+10
| +7% | +$867 | ﹤0.01% | 489 |
|
|
2021
Q3 | $11K | Hold |
140
| – | – | ﹤0.01% | 502 |
|
|
2021
Q2 | $12K | Hold |
140
| – | – | ﹤0.01% | 463 |
|
|
2021
Q1 | $11K | Hold |
140
| – | – | ﹤0.01% | 449 |
|
|
2020
Q4 | $12K | Hold |
140
| – | – | ﹤0.01% | 420 |
|
|
2020
Q3 | $11K | Hold |
140
| – | – | ﹤0.01% | 397 |
|
|
2020
Q2 | $17K | Hold |
140
| – | – | ﹤0.01% | 348 |
|
|
2020
Q1 | $12K | Hold |
140
| – | – | ﹤0.01% | 362 |
|
|
2019
Q4 | $12K | Hold |
140
| – | – | ﹤0.01% | 413 |
|
|
2019
Q3 | $9K | Hold |
140
| – | – | ﹤0.01% | 415 |
|
|
2019
Q2 | $12K | Hold |
140
| – | – | ﹤0.01% | 408 |
|
|
2019
Q1 | $12K | Hold |
140
| – | – | ﹤0.01% | 382 |
|
|
2018
Q4 | $12K | Buy |
+140
| New | +$12K | ﹤0.01% | 353 |
|
|
2018
Q3 | – | Sell |
-140
| Closed | -$13K | – | 506 |
|
|
2018
Q2 | $13K | Hold |
140
| – | – | ﹤0.01% | 368 |
|
|
2018
Q1 | $11K | Hold |
140
| – | – | ﹤0.01% | 366 |
|
|
2017
Q4 | $12K | Hold |
140
| – | – | ﹤0.01% | 352 |
|
|
2017
Q3 | $13K | Buy |
+140
| New | +$13K | ﹤0.01% | 336 |
|
|
2016
Q4 | – | Sell |
-86
| Closed | -$8K | – | 590 |
|
|
2016
Q3 | $8K | Buy |
+86
| New | +$8K | ﹤0.01% | 1083 |
|